The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification of patients at high risk for relapse using the Merlin Assay (CP-GEP) in an independent cohort of 451 patients (pts) with stage I/II melanoma who did not undergo sentinel lymph node biopsy.
 
Teresa Amaral
Consulting or Advisory Role - CeCaVa; Delcath Systems; NeraCare GmbH; Novartis; Pierre Fabre
Research Funding - Agenus (Inst); AstraZeneca (Inst); BioNTech SE (Inst); Biotech IOB (Inst); BMS GmbH & Co. KG (Inst); HUYA Bioscience International (Inst); Immunocore (Inst); MSD (Inst); NeraCare GmbH (Inst); Novartis (Inst); Pfizer (Inst); Philogen (Inst); Regeneron (Inst); Replimune (Inst); Roche/Genentech (Inst); Sanofi Aventis GmbH (Inst); Skyline Diagnostics (Inst)
 
Eftychia Chatziioannou
No Relationships to Disclose
 
Alica Nuebling
No Relationships to Disclose
 
Lena Nanz
No Relationships to Disclose
 
Tobias Sinnberg
Research Funding - Novartis (Inst)
 
Heike Niessner
Research Funding - Novartis (Inst)
 
Djvalini Dwarkasing
Employment - Skyline Diagnostics
Leadership - SciBase; Skyline Diagnostics
Stock and Other Ownership Interests - Skyline Diagnostics
 
Tim Arentsen
Employment - Skyline Diagnostics
 
Christian Groß
Employment - Skyline Diagnostics
 
Alexander M. Eggermont
Stock and Other Ownership Interests - IO Biotech; Sairopa; Skyline Diagnostics
Honoraria - Agenus; BIOINVENT; BioNTech; BioNTech.; Brenus Pharma; CatalYm; Ellipses Pharma; GenOway; GlaxoSmithKline; IO Biotech; IQVIA; ISA Pharmaceuticals; Merck; MSD; Pfizer; Pierre Fabre; Sairopa; Scorpion Therapeutics; Sellas Life Sciences; Skyline Diagnostics; TigaTx; Trained Therapeutix Discovery
Consulting or Advisory Role - Agenus; BIOINVENT; BioNTech.; BioNTech.; Brenus Pharma; CatalYm; Ellipses Pharma; GenOway; GlaxoSmithKline; IO Biotech; IQVIA; ISA Pharmaceuticals; Merck; MSD; Pfizer; Pierre Fabre; Sairopa; Scorpion Therapeutics; Sellas Life Sciences; Skyline Diagnostics; TigaTx; Trained Therapeutix Discovery
Speakers' Bureau - Bristol-Myers Squibb.; Merck; MSD
 
Ulrike M. Leiter
Honoraria - Amirall Hermal; MSD; Novartis; Sanofi; Sun Pharma
Consulting or Advisory Role - Amirall Hermal; MSD; Novartis; Sanofi; Sun Pharma
Research Funding - MSD (Inst)
Travel, Accommodations, Expenses - Pierre Fabre; Sun Pharma
 
Lukas Flatz
Stock and Other Ownership Interests - Hookipa Pharma
Consulting or Advisory Role - Philogen
Research Funding - Hookipa Pharma; Mundipharma
Patents, Royalties, Other Intellectual Property - Hookipa Pharma
Travel, Accommodations, Expenses - Hookipa Pharma
 
Stephan Forchhammer
Honoraria - Recordati
Research Funding - BioNTech SE (Inst); NeraCare GmbH (Inst); Skyline Diagnostics (Inst)